GLP-1
Treatment Review
← Peptide library

The evidence reference

Tesamorelin

Egrifta WR

Approved product

Sources checked 2026-10-27

Reading this profile

Pay attention to the boundaries of the thing being measured. Record the outcome's definition, units, and method before deciding what a reported change means. If a headline substitutes a familiar term for a more specific measurement, compare the two descriptions carefully. Also check whether change is expressed from the starting value, against another group, or both; these answer different questions. A useful reading note should preserve enough detail that the outcome cannot silently turn into a broader claim. When the terms remain distinct, the reader can see exactly which question the report addressed.

Formulation and route

Specified subcutaneous formulation.

Mechanism

Stimulates growth-hormone release.

Research evidence

A randomized trial measured visceral fat.

Limits of the evidence

Not for weight management.

Safety context

Active malignancy is a contraindication.

Questions to take further

  1. How does the report define the outcome and its measurement method?
  2. Does the headline preserve that definition or substitute a broader term?
  3. Is the reported change relative to baseline, another group, or both?

Original sources

  1. EGRIFTA WRNLM · Checked 2026-10-27
  2. Falutz trialPubMed · Checked 2026-10-27

Continue your research

An educational reference from the Comparison Desk. AI-assisted; not reviewed by a licensed clinician. This library does not provide prescriptions or instructions for self-treatment.